Impact Factor
3.14
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.20
459 total citations
h5-index
27
h5 depth signal
Cited share
60.3%
129 of 214
Total citations
459
Citation footprint
Metric signal
2.30
External metric anchor
Self-citation
7.6%
35 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
747
Italy
117
China
66
Canada
46
Japan
44
Citing Fields of Research
Oncology
400
Clinical Laboratory Science
251
Lung Cancer
202
Endocrinology & Metabolism
176
Musculoskeletal & Nerve Cancer
121
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,068
Articles tracked across the journal lifetime
Indexed publication set
214
129 cited publications
Last 12 months
107
8.9 publications/month
Open access share
36.4%
39 OA publications in the last year
Leading citing country
United States
747 citing publications
Leading citing field
Oncology
400 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v118n1, Feb. 2010-
v118n1, Feb. 2010-
Research Focus & Classification
Indexed Subjects
Oncology
Endocrinology & Metabolism
Lung Cancer
Clinical Laboratory Science
Musculoskeletal & Nerve Cancer
Issuing & Sponsoring Bodies
Contributor
American Cancer Society
Broad Categories
Neoplasms
Endocrinology & Metabolism
Lung Cancer
Oncology
Urology
Digestive Disorders
MeSH Descriptors
Cell Membrane
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/cncy.70150
Open DOI
Non‐small cell lung carcinoma and its mimics on cytology and small biopsy samples: a practical approach aligned with the WHO Reporting System
Accurate classification of lung tumors in cytology specimens and small biopsies remains a diagnostic challenge because of limited cellularity, preanalytical variables, and significant morphologic overlap among entities. This review summa...
02
03
DOI 10.1002/cncy.70159
Open DOI
Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study
Background: Immunohistochemistry (IHC) is essential for tumor subtyping and predictive biomarker analysis in non–small cell lung carcinoma (NSCLC). When only cytological material is available and no concurrent biopsy or cell block exists...
04
DOI 10.1002/cncy.70162
Open DOI
Issue Information
05
DOI 10.1002/cncy.70160
Open DOI
Preanalytical variables affect predictive immunohistochemical biomarker testing in non–small cell lung carcinoma cytology specimens
Background: Several therapeutic targets for non–small cell lung carcinoma (NSCLC) rely on protein expression by immunohistochemistry (IHC). Most biomarkers are validated on formalin‐fixed, paraffin‐embedded (FFPE) tissue; however, cytolo...
06
DOI 10.1002/cncy.70157
Open DOI
Stromal edge involvement in FNB of pancreatic ductal adenocarcinoma: An important diagnostic clue
Background: SharkCore fine‐needle biopsy (FNB) provides ample intact tissue for rapid on‐site evaluation and ancillary studies. Diagnosing well‐differentiated pancreatic ductal adenocarcinoma (PDAC) remains challenging, particularly in t...
07
Distinguishing mesothelioma from reactive mesothelial proliferations is a recurring problem in serous effusion and small‐biopsy practice, where invasion cannot be assessed and diagnosis rests on cell block immunohistochemistry. Loss of m...
08
DOI 10.1002/cncy.70151
Open DOI
The remarkable axolotl is helping to advance cancer research
This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this issue, the axolotl has become the salamander of...
09
DOI 10.1002/cncy.70158
Open DOI
Thank You to Reviewers 2026
10
DOI 10.1002/cncy.70154
Open DOI
Western versus Asian utilization of molecular testing for indeterminate thyroid nodules: A meta‐analysis of divergent clinical impact
Background: Molecular testing (MT) aids in the management of indeterminate thyroid nodules; however, regional differences remain unexamined. This meta‐analysis compares MT's clinical impact between Western and Asian cohorts. This study h...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
From 1997-2009 issued as every 3rd volume of Cancer, carrying its designation. Beginning with v.118 (2010), Cancer cytopathology issued independently.